About Neuropeptides B/W receptor type 1
Neuropeptides B/W receptor type 1 (NPBWR1) is a protein
from Homo sapiens identified by UniProt accession
P48145, 328 residues long.
MolForge cross-references it against 0 known binders and
45 disease associations.
Target properties
| Protein name | Neuropeptides B/W receptor type 1 |
| UniProt accession | P48145 |
| Gene | NPBWR1 |
| Organism | Homo sapiens |
| Length | 328 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (45)
Diseases linked to this target (Open Targets).
- age at menarche · score 0.33
- glioblastoma multiforme · score 0.26
- ovarian cancer · score 0.25
- adolescent idiopathic scoliosis · score 0.25
- breast adenocarcinoma · score 0.17
- head and neck squamous cell carcinoma · score 0.16
- leukemia · score 0.05
- obesity due to melanocortin 4 receptor deficiency · score 0.05
- obesity due to pro-opiomelanocortin deficiency · score 0.04
- hypoinsulinemic hypoglycemia and body hemihypertrophy · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P48145-F1 | alphafold | PREDICTED | 83.33 | — |
Amino-acid sequence (328 residues)
MDNASFSEPW PANASGPDPA LSCSNASTLA PLPAPLAVAV PVVYAVICAV GLAGNSAVLY VLLRAPRMKT VTNLFILNLA IADELFTLVL PINIADFLLR QWPFGELMCK LIVAIDQYNT FSSLYFLTVM SADRYLVVLA TAESRRVAGR TYSAARAVSL AVWGIVTLVV LPFAVFARLD DEQGRRQCVL VFPQPEAFWW RASRLYTLVL GFAIPVSTIC VLYTTLLCRL HAMRLDSHAK ALERAKKRVT FLVVAILAVC LLCWTPYHLS TVVALTTDLP QTPLVIAISY FITSLSYANS CLNPFLYAFL DASFRRNLRQ LITCRAAA
Explore Neuropeptides B/W receptor type 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets